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NFECTIOUS DISEASES IN THE DEVELOPING AND 
underdeveloped  world  are  prime  factors  re-
sponsible for poor health status and poverty.1,2 
The recent chikungunya viral epidemic in India high-
lights the impact of a debilitating infection in work-
ing  populations  and  its  particular  impact  on  those 
from low socioeconomic backgrounds. Chikungunya 
virus is a mosquito-transmitted alphavirus belonging 
to the family Togaviridae, and is endemic in Africa, 
India and Southeast Asia. It causes an acute infection 
of abrupt onset, characterized by high fever, arthral-
gia,  myalgia,  rash,  photophobia  and  retro-orbital 
pain.  Symptoms  generally  last  about  one  week  and 
recovery is usually complete.3 
  Almost  two  million  cases  were  reported  in  India 
between  February  and  August  2006.3  More  cases 
have  been  reported  in  2007.4,5  Despite  the  high 
prevalence of chikungunya infection there are no re-
ports  on  the  impact  of  poverty  and  socioeconomic 
profile on the spread of the disease or morbidity ex-
perienced.  
  We sought to determine the relation between pov-
erty  and  infection  using  a  cross-sectional,  hospital-
based study of 3541 consenting patients from three 
states  in  South  India  with  clinically  confirmed  chi-
kungunya  during  the  epidemic  from  February  to 
August 2006 (see Appendix for clinical criteria). We 
present  data  on  demographic  and  socioeconomic 
characteristics of the patients and on their period of 
morbidity.  
  Our findings reveal that 80% (2832/3541) of chi-
kungunya-affected  patients  were  below  the  poverty 
line according to the World Bank’s definition of in-
come  level  less  than  $1US  per  person  per  day  (the 
calculated average family size was 4.5). Almost two-
thirds (64%, 2250/3541) of infections occurred in the 
most productive age group of 15–45 years (mean 32; 
Table 1), and many (62%, 2189/3541) patients expe-
rienced morbidity related to their infection for more 
than 15 days. One-quarter (27.5%) suffered for more 
than  1  month  (Table  2).  High-income  participants 
(monthly  household  income  >  US$225)  reported  a 
significantly  longer  morbidity  period,  especially 
among those whose symptoms lasted longer than 30 
days  (p  <  0.0001)  (Table  2).  Infection  was  signifi-
cantly more common in lower income groups across 
all age groups (p < 0.0001).  
  Anecdotal evidence from our data collection sug-
gests that families of patients such as farm labourers 
or those working for a daily wage were often deprived 
of  meals  because  of  reduced  income.  Children  also 
suffered when affected mothers were unable to care 
for their daily nutritional requirements. Problems in 
achieving adequate nutrition also seemed to be exac-
erbated by many participants contracting simultane-
ous diarrheal infections. 
  Our data suggest that poverty is an important de-
terminant  of  chikungunya  infection,  and,  further, 
that chikungunya infection exacerbates the problems 
of poverty. Poor people are most commonly affected, 
and as a high  proportion are in the productive  work- 
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ing  age  group,  with  symptoms  in  many  lasting  for 
over 2 weeks, many suffer a lack of income as a re-
sult.  It  is  possible  that  the  observed  link  between 
poverty and infection can be partly explained by cur-
rent  research  showing  that  malnutrition  enhances 
individual susceptibility to infectious disease by low-
ering immunity.6  
  If this is the case, possible government interven-
tions include breaking the cycle of malnourishment, 
infection  and  further  malnourishment  by  providing 
therapeutic  food  formulations  to  poor  individuals. 
Funds  for  these  kinds  of  initiatives  are  available, 
given  that  half  the  central  government  funds  allo-
cated to fight chikungunya were unspent last  year.7 
That being said, we are concerned that state govern-
ment plans to initiate low-cost health coverage plans 
for those below the poverty line may be delayed be-
cause of the epidemic.7   
  The chikungunya epidemic also highlights the cen-
trality of governmental preventive measures for vector-
borne diseases, such as clearing vector breeding places, 
providing  health  education  on  preventing  mosquito 
bites, and so forth. Government support for research on 
infection and malnutrition is also clearly warranted for 
scientific, economic and ethical reasons.5  
  The impetus to control chikungunya infection goes 
beyond the individual: tourism to chikungunya-affected 
regions is depressed,8 and there is evidence of popula-
tion migration with attendant problems of overcrowd-
ing  and  poor  housing.9  These  could  also  exacerbate 
problems  of  poverty if employment requirements  are 
altered, e.g., for tourism-related activities. 
  Interestingly,  a  longer  duration  of  illness  is  re 
ported  in  high-income  participants,  especially  for 
those experiencing  morbidity  greater than 30 days. 
We propose that this may be because they can afford 
to  take  rest  until  complete  recovery,  while  manual 
labourers or those working for daily wages cannot af-
ford to do so. Further examination of this and the re-
lation  between  infection  and  nutritional  status  is 
warranted. 
  Our  results  should  be  interpreted  with  caution.  
Although we believe that patients attending the hos-
pitals  surveyed  are  representative  of  the  general 
population, it is possible that wealthier patients at-
tend private clinics. We believe this is unlikely, how-
ever, given that the participating hospitals had expert 
clinics for patients with chikungunya infections and 
that  the  participating  government  hospitals  have 
special  wards  for  high-income  patients  and  are 
teaching hospitals attached to highly respected medi-
cal colleges in India. A further limitation of our study 
is  that  we  relied  on  a  clinical  diagnosis  of  chikun-
gunya in the absence of a diagnostic test.  
  Although it is largely believed that complications 
of chikungunya are not serious, illness in individuals 
from  poor  backgrounds  can  have  serious  conse-
quences, such as reduced productivity at the individ-
ual and community level, malnutrition, other infec-
tions, socioeconomic instability and exacerbation of 
poverty. Attention to the links between poverty, ill-
ness and  human development are key in future re-
search and program development related to chikun-
gunya infection.  
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Appendix: inclusion and exclusion criteria 
Eligible patients  
•  had active clinical infection, including fever, polyarthralgia, 
rash, myalgia and retro-orbital pain with a minimum of at 
least 3 clinical symptoms  
•  had negative blood, sputum and urine investigations  
for dengue, malaria, typhoid, leptospirosis, syphilis and 
tuberculosis   
•  had no alternative medical explanation for their symptoms 
e.g., rheumatoid disease  
•  were successfully managed (completely relieved of their 
presenting clinical symptoms)  
•  were willing to participate in weekly follow-up.  
Excluded patients  
•  had taken alternative medical therapy such as Ayurveda, 
homeopathy, unani, etc. 
•  had chronic debilitating conditions or mental disorders 
precluding informed consent; or 
•  faced some unforeseen incident such as accident,  
fracture, etc. after enrolment. 